NCT03511326View on ClinicalTrials.gov

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

June 7, 2017

Primary Completion Date

November 28, 2017

Study Completion Date

November 28, 2017

Conditions

Actinic Keratoses

Interventions

DRUG

Methyl Aminolaevulinate 16% Cream

Subject will received one session of methyl aminolevulinate Daylight Photodynamic therapy

Trial Locations (1)

Unknown

University Hospital Regensburg, Regensburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY